Protocol Registration – Incretins-based diabetes drug does not increase risk of pancreatic cancer when compared to sulfonylureas

13 Jul Protocol Registration – Incretins-based diabetes drug does not increase risk of pancreatic cancer when compared to sulfonylureas

Posted at 13:13h in by

Redirecting to Project: Incretin-based drugs and the risk of pancreatic cancer (Q13-06B)